During the past decade, New York Proton Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New York Proton Center" #1 sponsor was "NRG Oncology" with 3 trials, followed by "Proton Collaborative Group" with 2 trials sponsored, "The New York Proton Center" with 2 trials sponsored, "Abramson Cancer Center at Penn Medicine" with 1 trials sponsored and "M.D. Anderson Cancer Center" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Proton Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator and "National Institute of Dental and Craniofacial Research (NIDCR)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "New York Proton Center" are "Breast Cancer" (3 trials), "Prostate Cancer" (3 trials), "Breast Neoplasm" (1 trials), "Breast Tumor" (1 trials) and "CNS Cancer" (1 trials). Many other conditions were trialed in "New York Proton Center" in a lesser frequency.

Most popular intervention types in "New York Proton Center" are "Radiation" (10 trials), "Other" (3 trials), "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intensity-Modulated Radiation Therapy" (3 trials), "Quality-of-Life Assessment" (3 trials), "Laboratory Biomarker Analysis" (2 trials), "Paclitaxel" (2 trials) and "Proton Beam Radiation Therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "New York Proton Center" are 7 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "New York Proton Center". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in New York Proton Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New York Proton Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".